MAGE-A1–6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes
Conclusion
In our patient group the expression of MAGE-A1–6 subtypes in tumor tissues of patients with HNSCC was correlated with advanced clinical stage of cancer and poor oncologic outcomes. We suggest that gene expression of MAGE-A1–6 subtypes may be considered to be a predictive factor to determine patient treatment or follow-up strategy.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Borderline Tumor | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Genetics | Head and Neck Cancer | HNSCC | Hypopharyngeal Cancer | Laryngeal Cancer | Melanoma | Oral Cancer | Oral Cavity Cancer | Oropharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma